(Q33475484)

27 July 2017

1 reference

title

Current management of metastatic brain disease (English)

1 reference

27 July 2017

Tulika Ranjan

1

1 reference

27 July 2017

Lauren E Abrey

series ordinal

2

1 reference

27 July 2017

publication date

1 July 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

6

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

598-603

1 reference

https://scigraph.springernature.com/pub.10.1016/j.nurt.2009.04.012

27 July 2017

exact match

0 references

cites work

Stereotactic radiosurgery for the treatment of brain metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Brain metastases: the HER2 paradigm

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Seizure prophylaxis in patients with brain tumors: a meta-analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

The effect of temozolomide-based chemotherapy in patients with cerebral metastases from melanoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Management of brain metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Demographics of brain metastasis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Brain metastases in children.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Chemotherapy induces regression of brain metastases in breast carcinoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Brain metastasis in hypernephroma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Radiation-induced dementia in patients cured of brain metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Surgical management of brain metastases: how aggressive should we be?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Response of brain metastases from breast cancer to systemic chemotherapy

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

Taxol sensitizes human astrocytoma cells to radiation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5084194

First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study

28 July 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Brain metastasis from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Brain metastases from colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Results of a randomized comparison of radiotherapy and bromodeoxyuridine with radiotherapy alone for brain metastases: report of RTOG trial 89-05.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Surgical resection and permanent iodine-125 brachytherapy for brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Gefitinib as palliative therapy for lung adenocarcinoma metastatic to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Gefitinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

A biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, temozolomide (Temodal), interferon-alfa and interleukin-2 for metastatic melanoma: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.NURT.2009.04.012

Solitary brain metastases treated with the Leksell gamma knife: prognostic factors for patients

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

The combined use of radiation therapy and lonidamine in the treatment of brain metastases

1 reference

12 December 2020

A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)

1 reference

12 December 2020

Systemic high-dose intravenous methotrexate for central nervous system metastases

1 reference

12 December 2020

Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy

1 reference

12 December 2020

Radiation therapy for brain metastases

1 reference

12 December 2020

Randomized trial of radiotherapy versus radiotherapy plus metronidazole for the treatment metastatic cancer to brain. A Southwest Oncology Group study

1 reference

12 December 2020

Management of brain metastases

1 reference

12 December 2020

The palliation of brain metastases in a favorable patient population: A randomized clinical trial by the radiation therapy oncology group

1 reference

12 December 2020

Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer

1 reference

12 December 2020

10.1016/J.NURT.2009.04.012

Identifiers

DOI

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference